Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 6
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean giuseppe facundo (4 results)?
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule.
Facondo G, Vullo G, Sanctis V, Vitiello C, Nieddu L, Alfò M, Scaringi C, Felice F, Rotondi M, Giacomo F, Ruscito I, Valeriani M, Osti MF. Facondo G, et al. J Contemp Brachytherapy. 2022 Aug;14(4):341-346. doi: 10.5114/jcb.2022.119198. Epub 2022 Aug 31. J Contemp Brachytherapy. 2022. PMID: 36199948 Free PMC article.
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
De Matteis S, Facondo G, Valeriani M, Vullo G, De Sanctis V, Ascolese AM, Campanella B, Scalabrino G, Osti MF. De Matteis S, et al. Among authors: facondo g. Clin Breast Cancer. 2022 Apr;22(3):e332-e340. doi: 10.1016/j.clbc.2021.09.008. Epub 2021 Sep 25. Clin Breast Cancer. 2022. PMID: 34670727 Free article.
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer.
DE Sanctis V, Facondo G, Vullo G, Anzellini D, Sanguineti G, Nardangeli A, Marmiroli L, Tortoreto F, Gentile P, Annessi I, Donato V, Chiostrini C, Tombolini V, DE Felice F, Valeriani M, Osti MF. DE Sanctis V, et al. Among authors: facondo g. Cancer Diagn Progn. 2023 Mar 3;3(2):194-200. doi: 10.21873/cdp.10201. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875316 Free PMC article.
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
DE Sanctis V, DI Rocco A, Cox MC, Valeriani M, Congedi FP, Anzellini D, Massaro M, Vullo G, Facondo G, DE Giacomo F, Alfò M, Prosperi D, Pizzichini P, Pelliccia S, Tafuri A, Martelli M, Osti MF. DE Sanctis V, et al. Among authors: facondo g. In Vivo. 2020 May-Jun;34(3):1407-1413. doi: 10.21873/invivo.11921. In Vivo. 2020. PMID: 32354938 Free PMC article.
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study.
Anzellini D, DE Sanctis V, Valeriani M, Reverberi C, Marinelli L, Massaro M, Vullo G, Facondo G, Sigillo RC, Tosi E, Osti MF. Anzellini D, et al. Among authors: facondo g. Anticancer Res. 2021 Oct;41(10):5107-5116. doi: 10.21873/anticanres.15327. Anticancer Res. 2021. PMID: 34593461 Clinical Trial.
16 results